Molecular Formula | C21H19F4N7
|
Molar Mass | 445.42 |
Solubility | DMSO: ≥ 4.5 mg/mL |
Appearance | solid |
Color | Yellow |
Storage Condition | RT (des.) |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or DMF may be stored at -20° for up to 3 months. |
Use | LY-2584702 free base is an ATP competitive selective p70S6K inhibitor with an IC50 of 4 nM. The IC50 of LY-2584702 inhibition of S6K1 is 2 nM. |
In vitro study | In HCT116 colon cancer cells, LY2584702 inhibited phosphorylation of S6 ribosomal protein (pS6) with IC50 of 0.1-0.24 μm. When LY258470 is combined with the EGRF inhibitor erlotinib or the mTOR inhibitor everolimus, there is a significant synergistic effect. |
In vivo study | LY2584702 (12.5 mg/kg BID) showed significant anti-tumor effects in U87MG glioblastoma and HCT116 colon cancer xenograft models. |